Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial
Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
treatment
Hydroxychloroquine for coronavirus shows no benefit, possible harm in study awaiting validation
An analysis of Veterans Health Administration (VA) data found that 28 per cent of 97 patients given hydroxychloroquine along with…
Using body clock improves patient outcomes for rheumatoid arthritis
A team of scientists have found evidence that co-ordinating the time of treatment with the timing of disease symptoms can increase…